AngioDynamics (NSDQ:ANGO) shares ticked up this morning on fourth-quarter results that beat the consensus revenue forecast. The Latham, N.Y.-based peripheral artery disease (PAD) treatment developer posted losses of -$19.5 million, or -51¢ per share, on sales of $76.8 million for the three months ended May 31, 2021, for an 87.6% bottom-line gain on sales growth […]
Wall Street Beat
Court orders Hillrom to proceed with BardyDx acquisition
The Court of Chancery in the state of Delaware ordered Hillrom (NYSE:HRC) to complete its planned acquisition of BardyDx. In March, Hillrom reversed course on the planned $375 million acquisition of Bardy Diagnostics and its Carnation Ambulatory Monitor, or CAM patch, claiming that closing conditions weren’t met. Hillrom’s u-turn came in the wake of regional […]
MedTech 100 roundup: Industry continues climb
One week after hitting an all-time best mark, the medtech industry has done it again, reaching new heights on Wall Street. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — continued its rise, finishing the week (July 9) at 114.79 points, a rise of 0.2% from the 114.59-point mark […]
Cigarette maker spending $1.2 billion on company with inhaled medical therapies
Philip Morris (NYSE:PM) announced today that it agreed to acquire inhaled drug delivery technology developer Vectura for $1.2 billion. New York-based Philip Morris agreed with the board of Vectura Group on the all-cash, recommended offer under which Vectura shareholders would be entitled to receive $2.07 per share (150 pence), representing a 46% premium to the ex-dividend closing […]
Lumos Diagnostics raises $46.8M in Australian IPO
Lumos Diagnostics announced today that it raised $46.8 million ($63 million AUD) in an initial public offering in Australia. Sarasota, Fla.-based Lumos (which has its corporate head offices in Melbourne, Australia), a fully integrated developer and manufacturer of custom point-of-care diagnostic tests, was admitted to the Australian Securities Exchange (ASX) with trading commencing after July […]
SEC claims Parallax Health Sciences, execs misled about COVID-19 tests, PPE
The SEC announced today that it levied a complaint against Parallax Health Sciences and two top executives for making allegedly misleading statements about COVID-19-related products. Without admitting or denying the allegations, Parallax, its CEO Paul Arena, and CTO Nathaniel Bradley consented to judgments permanently enjoining them from future violations of the charged provisions and requiring […]
MedTech 100 roundup: New all-time best reached
Once again, the medtech industry has soared to new heights, eclipsing its all-time best performance by the tiniest of margins. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished the week (July 2) at 114.59 points. It was just 0.01 points ahead of the 114.58-point mark set in […]
Belluscura is back with an IPO in the U.K.
Belluscura last month filed for an initial public offering (IPO) more than three years after pulling its plans for going public in the U.K. The London-based company with U.S. headquarters in Plano, Texas, on May 24 confirmed an issue price of approximately $24.2 million (£17.5 million) for placing on the AIM market of the London […]
Teleflex completes respiratory asset sale to Medline
Teleflex (NYSE:TFX) announced that it completed the divestiture of a significant portion of its respiratory business to Medline Industries. Wayne, Pa.-based Teleflex announced last month that it agreed to sell a significant portion of its respiratory business to Medline for $286 million, reduced by $12 million of working capital to be retained by Teleflex. The […]
MedTech 100 roundup: Nearing new highs once again
Having hit a downturn as the summer neared, the medtech industry is now consistently on the rise as June comes to a close. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished the week (June 25) at 113.42 points, producing a 2.5% rise from the 110.64-point mark set […]
Boston Scientific pulls trigger on Farapulse acquisition
Boston Scientific (NYSE:BSX) announced today that it exercised its option to acquire the remaining shares of Farapulse. Marlborough, Mass.-based Boston Scientific first announced its intent to acquire Farapulse in September 2020, when it signed an investment agreement with an option to acquire the pulsed-field ablation (PFA) technology developer. Boston Scientific has been an investor in […]
